Plasma monoamine metabolites and aggression: two studies of normal and oppositional defiant disorder children

Author： van Goozen S.H.M.   Matthys W.   Cohen-Kettenis P.T.   Westenberg H.   van Engeland H.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.9, Iss.1, 1999-01, pp. : 141-147

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Psychopharmacological Treatment of Oppositional Defiant Disorder

By Turgay Atilla  

CNS Drugs, Vol. 23, Iss. 1, 2009-01 ,pp. : 1-17

Adis International

Access to resources Recommend Favorite

Effect of comorbid symptoms of oppositional defiant disorder on responses to atomoxetine in children with ADHD: a meta-analysis of controlled clinical trial data

By Biederman Joseph   Spencer Thomas   Newcorn Jeffrey   Gao Haitao   Milton Denái   Feldman Peter   Witte Michael  

Psychopharmacology, Vol. 190, Iss. 1, 2007-01 ,pp. : 31-41

Springer Publishing Company

Access to resources Recommend Favorite

Effects of clozapine on plasma monoamine metabolites in treatment-refractory schizophrenic patients

By Min-Soo L.   Seung-Hyun K.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 341-342

Elsevier

Access to resources Recommend Favorite

Effects of Guanfacine Extended Release on Oppositional Symptoms in Children Aged 6-12 Years with Attention-Deficit Hyperactivity Disorder and Oppositional Symptoms: A Randomized, Double-Blind, Placebo-Controlled Trial

By Connor Daniel F.  

CNS Drugs, Vol. 24, Iss. 9, 2010-09 ,pp. : 755-768

Adis International

Access to resources Recommend Favorite

Identifying Genetic Variants in Adolescents With Oppositional Defiant Disorders and/or Conduct Disorders: A Brief Report

By  

Journal Of Child And Adolescent Psychiatric Nursin G (Electronic), Vol. 29, Iss. 3, 2016-08 ,pp. : 154-157

John Wiley & Sons Inc

Access to resources Recommend Favorite